Data as of Aug 29
| +0.03 / +2.17%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +396.45% increase from the last price of 1.41.
The current consensus among 4 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.